SEC Form 4 · accession 0001762003-19-000002
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Boston Foundation, Inc.
10% Owner
Period of report
Jan 9, 2019
Accepted (ET)
Jan 10, 2019 · 9:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 | Jan 9, 2019 | S | 337,000 | $0.3675 | D | 1,600,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Price reported of $0.3675 is the weighted average price of the sales prices received for the stock sales during the day of 1/9/2019.